Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol
NCT05853627Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propranolol in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Composite score of psychophysiological reactivity at 11 weeks. Started Jun 2023; status: recruiting.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05853627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853627.